Chen long Wang et al. found that inhibition of CYP4X1 in TAMs can prolong the survival time of glioma patients and normalize tumour blood vessels through the CB2 and EGFR-STAT3 signalling pathways38. This evidence concerns the gene EGFR and central nervous system cancer.